Scott Matusow

About the Author Scott Matusow

StockMatusow.com is Scott Matusow; Team Leader, co-owner and founder of StockMatusow.com and Dan Cohen, co-owner, and independent investor/scientist/inventor/trader and lead contributor at stockmatusow.com. Scott is an independent investor/writer/trader and team leader of StockMatusow.com. He has have about 20 years of stock market experience which include trading, investing, and managing his family’s trust as well as his personal account. Scott has had the most success in trading/investing in smaller cap growth companies. Because Scott is not 'officially trained' in the markets, he see things outside the box, using his experience to provide clarity and alpha. Scott uses his ability to read situations, emotion, charts, times and sales, historical data, and macroeconomic and other market forces to predict stock price movements, in both short and longer terms situations. Using these acquired allowed for him to completely divest his own and family's money near the top of the market before the 2008 financial crisis. Dan Cohen is an entrepreneur in the fields of biotech, nanotechnology, medical diagnostics, and energy storage - Dan is also a Scientist and inventor. He has 7 years of experience investing and trading biotechnology focused equities with a specialty in identifying under-appreciated value in small caps. Dan utilizes his experience reading and reviewing scientific literature to evaluate prospects for success. His work with diagnostics development give him a strong background in immunology which is leveraged in evaluating immunology focused approaches. As well Dan has 5 years trading futures, specializing in E-minis and Treasury products. He utilizes a combination of technical analysis, deep scientific research, and macro views to generate alpha for the team. Places you can follow Scott are: www.stockmatusow.com http://www.twitter.com/StockMatusow @StockMatusow http://www.facebook.com/TheScottMatusowShow Places to follow Dan are: https://twitter.com/biosleuth and www.stockmatusow.com

Wall Street’s #1 Analyst Believes in These 3 Buy-Rated Stocks

We all want to make the best decisions in our investing, but how do we know where and how to allocate our funds? …

2 Under the Radar Biotechs Poised to Run

Written by Daniel Cohen and Scott Matusow Lately, many early stage developmental biotech companies have been going on some seriously epic runs. Karuna …

Texas Mineral Resources (TMRC): This Rare Earth Metal Play Could See Substantial Upside

Texas Mineral Resources (TMRC) is a unique play in the rare earth space, which has been developing a new methodology to extract these …

3 Small Cap Biotechs with Upcoming Catalysts

Written by Danny Cohen of stockmatusow.com BiolineRx (BLRX) is slated to report on complete data at the European Society for Medical Oncology (ESMO) …

3 Biotechs with Upcoming Data to Watch

Written by Dan Cohen and Scott Matusow Cytokinetics (NASDASQ:CYTK) looks to turn around their fortunes following last year’s unsuccessful readout of Tirasemtiv in …

Recent Sell-Off in Jounce therapeutics’ (JNCE) Stock Is Unwarranted

Written by Dan Cohen In the wake of recently revealed abstracts from the 2018 ASCO meeting, Jounce therapeutics (NASDAQ:JNCE) stock price recently took …

4 Biotechs with Near Term Catalysts: G1 Therapeutics, Inc. (GTHX), Sierra Oncology Inc (SRRA), Myokardia Inc (MYOK), Jounce Therapeutics (JNCE)

Written by Danny Cohen and Scott Matusow The biotech “run-up” trade has always attracted a wide-array of traders looking to take advantage of …

There’s More Than Meets The Eye With Calithera Biosciences

Written by Danny Cohen And Scott Matusow This past weekend at The Society for Immunotherapy of Cancer (SITC) Calithera Biosciences Inc (NASDAQ:CALA) presented a …

4 Biotechs to Keep an Eye on for the Annual Ash Meeting

Written by Dan Cohen and Scott Matusow from Stockmatusow.com.

Myokardia Inc: A New Approach in Cardiomyopathy Treatment

Written by Dan Cohen and Scott Matusow Currently, we are in the midst of a dramatic shift in the field of biotechnology and …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts